Analysis of factors involved in brain-death donor processing for face transplantation in Korea: How much time is available from brain death to transplantation?

Background Face transplantation has naturally evolved from reconstructive procedures. However, few institutions perform face transplantations, because it is time-consuming and it is necessary to justify non-vital organ transplantation. We investigated the process of organ donation from brain-dead patients and the possibility of incorporating face transplantation into the donation process.

Methods A retrospective review was performed of 1,074 brain-dead patients from January 2015 to December 2016 in Korea. We analyzed the time intervals from admission to brain death decisions (first, second, and final), the causes of brain death, and the state of the transplanted organs.

Results The patient base (n=1,074) was composed of 747 males and 327 females. The average period between admission to the first brain death decision was 8.5 days (±15.3). The average time intervals between the first brain death decision and medical confirmation using electroencephalography and between the first brain death decision and the final determination of brain death were 16 hours 58 minutes (±14 hours 50 minutes) and 22 hours 57 minutes (±16 hours 16 minutes), respectively. The most common cause of brain death was cerebral hemorrhage/stroke (42.3%), followed by hypoxia (30.1%), and head trauma (25.2%).

Conclusions When face transplantation is performed, the transplantation team has 22 hours 57 minutes on average to prepare after the first brain death decision. The cause of brain death was head trauma in approximately one-fourth of cases. Although head trauma does not always imply facial trauma, surgeons should be aware that the facial tissue may be compromised in such cases.

Keywords

Brain death - Transplantation - Tissue and organ procurement

We thank Kyoung Ock Jeon, Sun Young Son, and Dong Uk Kim Department of Transplantation Surgery, Severance Hospital, who are transplantation coordinator for brain death patient data. And we also appreciate Korean Network for Organ Sharing (KONOS) for data sharing.

Publication History

Received: 25 January 2019

Accepted: 03 July 2019

Article published online:
03 April 2022

• REFERENCES

• 1 Lindford AJ, Makisalo H, Jalanko H. et al. The Helsinki approach to face transplantation. J Plast Reconstr Aesthet Surg 2019; 72: 173-80
• 2 Sosin M, Rodriguez ED. The face transplantation update: 2016. Plast Reconstr Surg 2016; 137: 1841-50
• 3 Kiwanuka H, Bueno EM, Diaz-Siso JR. et al. Evolution of ethical debate on face transplantation. Plast Reconstr Surg 2013; 132: 1558-68
• 4 Nguyen LL, Naunheim MR, Hevelone ND. et al. Cost analysis of conventional face reconstruction versus face transplantation for large tissue defects. Plast Reconstr Surg 2015; 135: 260-7
• 5 Siemionow M. Face transplantation: a leading surgeon’s perspective. Transplant Proc 2011; 43: 2850-2
• 6 Pomahac B. Establishing a composite tissue allotransplantation program. J Reconstr Microsurg 2012; 28: 3-6
• 7 Knobloch K, Rennekampff HO, Vogt PM. Face as an organ: a political dimension in the European Union. Ann Plast Surg 2009; 62: 335
• 8 Min SI, Ha J. Recent progresses in organ donation and transplantation in Korea. Transplantation 2015; 99: 2431-3
• 9 Morrissey PE, Monaco AP. Donation after circulatory death: current practices, ongoing challenges, and potential improvements. Transplantation 2014; 97: 258-64
• 10 Jericho BG. Organ donation after circulatory death: ethical issues and international practices. Anesth Analg 2019; 128: 280-5
• 11 Waters CE, French G, Burt M. Difficulty in brainstem death testing in the presence of high spinal cord injury. Br J Anaesth 2004; 92: 760-4
• 12 Korean Statistical Information Service (KOSIS). Statistics of blood donation by blood type [Internet]. Daejeon: KOSIS; c2019 [cited 2019 Jan 7]. Available from: http://kosis.kr/statHtml/statHtml.do?orgId=445&tblId=DT_445001_006&vw_cd=MT_ZTITLE&list_id=D1_445001&seqNo=&lang_mode=ko&language=kor&obj_var_id=&itm_id=&conn_path=MT_ZTITLE
• 13 Devauchelle B, Badet L, Lengele B. et al. First human face allograft: early report. Lancet 2006; 368: 203-9
• 14 MacKay BJ, Nacke E, Posner M. Hand transplantation--a review. Bull Hosp Jt Dis (2013) 2014; 72: 76-88
• 15 Kuo YR, Chen CC, Chen YC. et al. The first hand allotransplantation in Taiwan: a report at 9 months. Ann Plast Surg 2016; 77: S12-5
• 16 Guo S, Han Y, Zhang X. et al. Human facial allotransplantation: a 2-year follow-up study. Lancet 2008; 372: 631-8
• 17 Ozkan O, Ertosun MG, Ozkan O. Technical, immunological, and ethical similarities and differences between vascularized composite allotransplantation and solid organ transplantation in current practice. Transplant Proc 2018; 50: 3775-82
• 18 Kim YJ. The first hand transplant in Korea... then, face off?. The Dong’A Ilbo. 2017 Feb 21. Available from: http://news.donga.com/3/all/20170220/82962288/1
• 19 Enforcement decree of the Internal Organs, etc. Transplantation Act of 2008, Pub. No. 29230 (2018 Oct 16)
• 20 Morris P, Bradley A, Doyal L. et al. Face transplantation: a review of the technical, immunological, psychological and clinical issues with recommendations for good practice. Transplantation 2007; 83: 109-28
• 21 Clarke A, Butler PE. Patient selection for facial transplantation II: psychological considerations. Int J Surg 2004; 2: 116-7
• 22 Johnson SE, Corsten MJ. Facial transplantation in a new era: what are the ethical implications?. Curr Opin Otolaryngol Head Neck Surg 2009; 17: 274-8
• 23 Siemionow M, Gordon CR. Overview of guidelines for establishing a face transplant program: a work in progress. Am J Transplant 2010; 10: 1290-6
• 24 Pomahac B, Diaz-Siso JR, Bueno EM. Evolution of indications for facial transplantation. J Plast Reconstr Aesthet Surg 2011; 64: 1410-6
• 25 Hong JW. Analysis of the processing time from the brain death to transplantation for the face transplantation. Proceedings of the 9th Korea Japan Transplantation Forum; 2012 Oct 19-20; Incheon, Korea. Abstract No. 12B-093.